VitaNova Life Sciences (VNOV) Assets Average (2018 - 2026)

VitaNova Life Sciences' Assets Average history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Assets Average rose 80.16% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $2.3 million (up 80.16% YoY) and the FY2025 annual result came in at $1.7 million, up 187.05% from the prior year.
• Assets Average was $2.3 million for Q1 2026 at VitaNova Life Sciences, up from $2.3 million in the prior quarter.
• Across five years, Assets Average topped out at $2.3 million in Q1 2026 and bottomed at $9870.5 in Q2 2023.
• A 5-year average of $972021.9 and a median of $1.1 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average plunged 69.82% — and 2024, when it surged 10827.58%.
• VitaNova Life Sciences' Assets Average stood at $32537.0 in 2022, then sank by 69.66% to $9870.5 in 2023, then soared by 12359.67% to $1.2 million in 2024, then surged by 86.15% to $2.3 million in 2025, then advanced by 1.52% to $2.3 million in 2026.
• Business Quant data shows VNOV's Assets Average at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.